维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

17篇 您的检索式：作者名="Butrynski"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor 显示文摘	BUTRYNSKI J E D' ADAMO D R HOMICK J L	2010	N Engl J Med2010，363，：	1
	2	Crizotinib in ALK-re- arranged inflammatory rayofibroblastic tumor 显示文摘	Butrynski JE D'Adamo DR Hornick JK	2010	The New England journal of medicine2010，363，18：	1
	3	Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor 显示文摘	Butrynski JE D'Adamo DR Hornick JL	2010	N Engl J Med2010，363，18：	1
	4	Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor显示文摘	Butrynski JE D'Adamo DR Homick JL	2010	New Engl J Med2010，363，：	1
	5	Sunitinib treatment of pediatric metastatic GIST after failure of imatinib 显示文摘	JANEWAY KA MATTHEWS DC BUTRYNSKI J E	2006	J Clin Oncol2006，24，18：	1
	6	Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors 显示文摘	HAWKINS D S SCHUETZE S M BUTRYNSKI J E	2005	J Clin Oncol2005，23，34：	1
	7	Primary extragastrointestinal stromal tumor of the pleura:report of a unique case with genetic confirmation显示文摘	Long KB Butrynski JE Blank SD		0，，6：	1
	8	Crizotinib inALK-rearranged inflammatory myofibroblastic tumor 显示文摘	Butrynski JE D5Adamo DR Homick JL	2010	NEngl J Med2010，363，18：	1
	9	Efficacy and Safety of Regorafenib in Patients With Metastatic and/or Unresectable GI Stromal Tumor After Failure of Imatinib and Sunitinib: A Multicenter Phase II Trial显示文摘	Suzanne George Qian Wang Michael C. Heinrich Christopher L. Corless Meijun Zhu James E. Butrynski Jeffrey A. Morgan Andrew J. Wagner Edwin Choy William D. Tap Jeffrey T. Yap Annick D. Van den Abbeele Judith B. Manola Sarah M. Solomon Jonathan A. Fletcher	2012	Journal of Clinical Oncology2012，，19：	1
	10	Crizontinib in ALK- rearranged inflammatory myofibroblastic tumor显示文摘	Butrynski JE D'Adamo DR Hornick JL	2010	N Engl J Med2010，363，18：	1
	11	Phase II stud- y of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy 显示文摘	CHOY E BUTRYNSKI JE HARMON DC	2014	BMC Cancer2014，14，1：	1
	12	A phase Ⅰ study of the safety and pharmacokinetics of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma显示文摘	Ganjoo KN Cranmer LD Butrynski JE	2011	Oncology2011，80，12：	1
	13	Primary extragastrointesti- nal stromal tumor of the pleura : report of a unique case with genetic confirmation 显示文摘	Long KB Butrynski JE Blank SD	2010	Am J Surg Patho12010，34，6：	1
	14	Crizotinibin ALK-rearranged inflammatory myofibroblastic tumor显示文摘	Butrynski JE D'Adamo DR Hornick JL	2010	NEngl J Med2010，363，18：	1
	15	18F-fluorodeoxy-D-glucosepositron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults显示文摘	Hawkins DS Conrad EU 3rd Butrynski JE	2009	Cancer2009，115，15：	1
	16	Cytoreductive Surgery in Patients with Metastatic Gastrointestinal Stromal Tumor Treated with Sunitinib Malate显示文摘	Chandrajit P. Raut MD MSc Qian Wang PhD Judith Manola MS Jeffrey A. Morgan MD Suzanne George MD Andrew J. Wagner MD PhD James E. Butrynski MD PhD Christopher D. M. Fletcher MD George D. Demetri MD Monica M. Bertagnolli MD	2010	Annals of Surgical Oncology2010，，2：	1
	17	A Phase I Study of the Safety and Pharmacokinetics of the Hypoxia-Activated Prodrug TH-302 in Combination with Doxorubicin in Patients with Advanced Soft Tissue Sarcoma显示文摘	Ganjoo KN Cranmer LD Butrynski JE	2011	Oncology2011，80，12：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费